Les plastoglobules sont de petites particules localisées au niveau des plastes qui stockent des lipides neutres tels que les triacylglycérols (TAG), du tocophérol et des caroténoïdes. Leurs nombre et diamètre changent en fonction de l’espèce de plante, du type de plaste, du stade de développement et des conditions environnementales. Dans les chloroplastes, les plastoglobules sont liés physiquement aux thylacoïdes par une monocouche de lipides polaires en continuité avec le feuillet externe des thylacoïdes. Ceci suggère qu’il y a une dynamique d’échange de métabolites tels que les lipides entre les deux compartiments. Cependant, la composition lipidique des plastoglobules est mal décrite. L’objectif de ce travail a été d’établir la nature exacte des lipides des plastoglobules en condition de culture standard par TLC/GC-FID suivie d’une étude par LC-MS/MS. Ces travaux ont montré que les plastoglobules sont composés majoritairement d’acides gras libres et de phytyls esters. En plus des lipides neutres, ils sont composés de galactolipides, de la PC et du PG de composition spécifique, riche en acides gras saturés, différente de celle des thylacoïdes et de l’enveloppe. Le deuxième objectif a été de définir l’origine des lipides des plastoglobules par l’étude de la cinétique de marquage des lipides en condition de stress. Ainsi, pendant le stress, une partie des acides gras issus de la dégradation des galactolipides des thylacoïdes sera à l’origine de la formation des phytyl esters puis stockée dans les plastoglobules. En conclusion, ces résultats suggèrent la présence de micro-domaines au niveau des thylacoïdes qui favoriseraient la formation des plastoglobules. / Plastoglobules are small lipoprotein particles localized inside plastids. They are surrounded by a monolayer of polar lipids, proteins and they store neutral lipids such as triacylglycerol, carotenoids and tocopherol. During plastid development or in response to stress conditions, plastoglobules increase in number and size along with thylakoids disintegration, and reciprocally, their number and size decrease while thylakoids are developing. Plastoglobules are surrounded by a leaflet contiguous with the thylakoid outer leaflet and therefore share a physical link with thylakoids. This connection suggests exchange of molecules between these two compartments. The protein composition of plastoglobules is well known. However, the lipid composition of plastoglobules is still unknown. Thereby, the aim of our study is, at first, to establish the nature and the origin of plastoglobules from Arabidopsis and pea leaves. Using TLC/GC-FID analysis and by LC-MS/MS we identified nature of the lipids composing the plastoglobules. Moreover, doing pulse and chase analysis during stress condition, we obtained information about the origin of plastoglobules lipids. Our results show that plastoglobules are composed in majority from neutral lipids, principally free fatty acids and phytyl esters. Moreover, plastoglobules contain polar lipids such as galactolipids and phospholipids (PC and PG) have a specific lipid composition different from the thylakoid leaflet and envelope. In addition, during stress conditions plastoglobules store phytyl esters coming from fatty acids of galactolipides in degradation. To summarize, the specific composition of plastoglobules suggest that microdomains might exist in thylakoids that would favor plastoglobule formation.

京都大学 / 新制・課程博士 / 博士(医学) / 甲第23088号 / 医博第4715号 / 新制||医||1050(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 柳田 素子, 教授 岩田 想, 教授 浅野 雅秀 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

京都大学 / 0048 / 新制・課程博士 / 博士(薬科学) / 甲第20311号 / 薬科博第80号 / 新制||薬科||9(附属図書館) / 京都大学大学院薬学研究科医薬創成情報科学専攻 / (主査)教授 岡村 均, 教授 竹島 浩, 准教授 平澤 明 / 学位規則第4条第1項該当 / Doctor of Pharmaceutical Sciences / Kyoto University / DGAM

Even though edible oils undergo refining processes to remove undesirable components, commercial oils still contain small amounts of minor components that can contribute to either prooxidant and antioxidant pathways which ultimately affect the quality of the oils. The objective of this research was to determine the role of free fatty acids and mono- and diacylglycerols on the oxidative stability of oil-in-water emulsions. Free fatty acids acted as a strong prooxidants in stripped soybean oil-in-water emulsions. Concentrations as low as 0.1% of the lipid accelerated lipid oxidation rate by both shortening the lag phase of lipid hydroperoxide and hexanal formation. The results showed that the most likely mechanisms for the prooxidant activity of free fatty acids is through their ability to increase the negatively charge on emulsion droplets that in turn could attract the cationic transition metals to the emulsion droplet surface where they can interact with lipid and thus promote oxidation. The prooxidant activity of free fatty acids was dependent on fatty acid type with lipid oxidation rates being in the order of linolenic < linoleic < oleic. Surprisingly, an increase in the degree of unsaturation of the free fatty viii acids lowered the ability of the free fatty acids to promote oxidation which may be due to their differences in geometric shape thus influencing their ability to access the emulsion droplet interface and increase the negative charge. Overall, free fatty acids are strong prooxidants in oil-in-water emulsions. This prooxidant activity is dependent not only on their concentration but also on the molecular structure of the fatty acid. Addition of mono- and diacylglycerols in oil-in-water emulsions showed an antioxidative effect in both non-stripped and stripped soybean oil. Addition of 1-monooleoylglycerol only had a small impact on the oxidative stability of non-stripped soybean oil-in-water emulsions but did inhibit lipid oxidation in emulsions prepared with stripped soybean. Much stronger antioxidant activity was observed upon the addition of 1,2-dioleoyl-sn-glycerol to both non-stripped and stripped soybean oil-in-water emulsions. Both lipid hydroperoxide and hexanal formation decreased with increasing 1,2-dioleoyl-sn-glycerol concentrations with 2.5% 1,2-dioleoyl-sn-glycerol almost completely preventing hydroperoxide and hexanal production over the course of the study. Overall, these results suggest that diacylglycerols could be an effective antioxidant in oil-in-water emulsions which possibility due to their ability to form a liquid crystal phase which could form a physical barrier that decreases interactions between unsaturated fatty acids in the emulsion droplet core and prooxidants or oxygen in the aqueous phase of the emulsion. However, the antioxidant mechanism of diacylglycerols is not currently understood and needs further investigation.

Biodiesel has emerged as a promising renewable and clean energy alternative to petrodiesel. While biodiesel has traditionally been prepared through homogeneous basic catalysis, heterogeneous acid catalysis has been investigated recently due to its ability to convert cheaper but high free fatty acid content oils such as waste vegetable oil while decreasing production cost. In this work, the esterification of free fatty acid over sulfated zirconia and activated acidic alumina in a batch reactor was considered. The models of the reaction over the catalysts were developed in two parts. First, a kinetic study was performed using a deterministic model to develop a suitable kinetic expression; the related parameters were subsequently estimated by numerical techniques. Second, a stochastic model was developed to further confirm the nature of the reaction at the molecular level. The esterification of palmitic acid obeyed the Eley-Rideal mechanism in which palmitic acid and methanol are adsorbed on the surface for SO?/ZrO?-550°C and AcAl?O? respectively. The coefficients of determination of the deterministic model were 0.98, 0.99 and 0.99 for SO?/ZrO?-550°C at 40, 60 and 80°C respectively and 0.99, 0.98 and 0.96 for AcAl?O? at the same temperature. The deterministic and stochastic models were in good agreement. / Master of Science

No / Background Oral administration of the omega-3 fatty acid eicosapentaenoic acid (EPA), as the free fatty acid (FFA), leads to EPA incorporation into, and reduced growth of, experimental colorectal cancer liver metastases (CRCLM). Design: We performed a Phase II double-blind, randomised, placebo-controlled trial of EPA-FFA 2 g daily in patients undergoing liver resection surgery for CRCLM. The patients took EPA-FFA (n=43) or placebo (n=45) prior to surgery. The primary end-point was the CRCLM Ki67 proliferation index (PI). Secondary end-points included safety and tolerability of EPA-FFA, tumour fatty acid content and CD31-positive vascularity. We also analysed overall survival (OS) and disease-free survival (DFS). Results The median (range) duration of EPA-FFA treatment was 30 (12–65) days. Treatment groups were well matched with no significant difference in disease burden at surgery or preoperative chemotherapy. EPA-FFA treatment was well tolerated with no excess of postoperative complications. Tumour tissue from EPA-FFA-treated patients demonstrated a 40% increase in EPA content (p=0.0008), no difference in Ki67 PI, but reduced vascularity in ‘EPA-naïve’ individuals (p=0.075). EPA-FFA also demonstrated antiangiogenic activity in vitro. In the first 18 months after CRCLM resection, EPA-FFA-treated individuals obtained OS benefit compared with placebo, although early CRC recurrence rates were similar. Conclusions EPA-FFA therapy is safe and well tolerated in patients with advanced CRC undergoing liver surgery. EPA-FFA may have antiangiogenic properties. Remarkably, limited preoperative treatment may provide postoperative OS benefit. Phase III clinical evaluation of prolonged EPA-FFA treatment in CRCLM patients is warranted. Trial Identifier: ClinicalTrials.gov NCT01070355. / The Cancer Research UK Clinical Trials Awards and Advisory Committee approved the Trial. PML and ADR were supported by Department of Health/Cancer Research UK Yorkshire Experimental Cancer Medicine Centre funding. The Trial was adopted by the UKCRN Clinical Trials Portfolio (UKCRN ID 8946) allowing West Yorkshire Comprehensive Local Research Network funding of Pharmacy costs. SLA Pharma AG funded some of the experimental work and provided EPA-FFA and placebo. SLA Pharma AG played no role in the design or execution of the Trial. Laboratory costs were also supported by the Leeds Teaching Hospitals Charitable Foundation (Rays of Hope).

No / Inflammatory bowel diseases are associated with increased risk of developing colitis-associated colorectal cancer (CAC). Epidemiological data show that the consumption of ω-3 polyunsaturated fatty acids (ω-3 PUFAs) decreases the risk of sporadic colorectal cancer (CRC). Importantly, recent data have shown that eicosapentaenoic acid-free fatty acid (EPA-FFA) reduces polyp formation and growth in models of familial adenomatous polyposis. However, the effects of dietary EPA-FFA are unknown in CAC. We tested the effectiveness of substituting EPA-FFA, for other dietary fats, in preventing inflammation and cancer in the AOM-DSS model of CAC. The AOM-DSS protocols were designed to evaluate the effect of EPA-FFA on both initiation and promotion of carcinogenesis. We found that EPA-FFA diet strongly decreased tumor multiplicity, incidence and maximum tumor size in the promotion and initiation arms. Moreover EPA–FFA, in particular in the initiation arm, led to reduced cell proliferation and nuclear β-catenin expression, whilst it increased apoptosis. In both arms, EPA-FFA treatment led to increased membrane switch from ω-6 to ω-3 PUFAs and a concomitant reduction in PGE2 production. We observed no significant changes in intestinal inflammation between EPA-FFA treated arms and AOM-DSS controls. Importantly, we found that EPA-FFA treatment restored the loss of Notch signaling found in the AOM-DSS control and resulted in the enrichment of Lactobacillus species in the gut microbiota. Taken together, our data suggest that EPA-FFA is an excellent candidate for CRC chemoprevention in CAC.

Thesis (MSc)--Stellenbosch University, 2012. / ENGLISH ABSTRACT: Background:Obesity is a growing global burden; current studies have projected the prevalence of obese / overweight individuals to increase to ~1.35 billion by 2030. A number of factors contribute to cardiovascular diseases, of which the focus of this study is what effect an increased level of free fatty acids has on the flux through the hexosamine biosynthetic pathway (HBP). It has been widely proven that an increased flux through the HBP causes an increase in protein O-GlcNAcylation, which leads to increased reactive oxygen species (ROS) production as well as an increase in cell death (apoptosis). Methods: For the purpose of this study a cell model was used. H9c2 cardiomyoblasts were cultured in 5ml Dulbecco‟s Modified Eagles Medium (DMEM) supplemented with 10% foetal bovine serum and 1% penicillin-streptomycin. The cells were then exposed to 0.25mM monounsaturated fatty acid (oleic acid) for 24, 48 and 72 hours respectively. The cultured cells were then evaluated to assess the degree ROS production, overall O-GlcNAcylation and cell death (apoptosis and necrosis), using flow cytometry and immunofluorescence microscopy. Results: We found that oleic acid causes a significant decrease in ROS production at the 48 hour time point when analysed on the flow cytometer, which indicates that oleic acid is metabolized by the cells in a independent manner. Oleic acid also caused a significant decrease in cell death at all the time intervals. With regard to the HBP, oleic acid activates this pathway but causes downstream cardioprotective effects that do not necessarily occur along this pathway. Conclusion: This study explored whether a monounsaturated fatty acid, oleic acid, is able to act as a novel cardioprotective agent. The in vitro data supports this concept and we showed that it is able to blunt oxidative stress and cell death. It was also found that although oleic acid activated the HBP, it did not mediate its protective effects via this pathway only. / AFRIKAANSE OPSOMMING: Agtergrond: Vetsug is 'n groeiende wêreldlas; huidige studies voorspel dat die voorkoms van vetsugtige / oorgewig individue toe sal neem tot ~1.35 biljoen teen 2030. Alhoewel verskeie faktore tot kardiovaskulêre siektes bydra is die fokus van hierdie studie om die effek van verhoogde vryvetsuurvlakke op die fluks deur die heksosamienbiosintestiese weg (HBW) te ondersoek. Dit is reeds bewys dat verhoogde fluks deur die HBW 'n verhoging in proteïen O-GlcNAsilering lei, wat verder tot verhoogde reaktiewe suusrtofspesies (ROS) vorming aanleiding gee en ook seldood (apoptose) verhoog. Metodes:'n Selmodel is vir die doel van hierdie studie gebruik. H9c2 kardiomioblaste is in 5ml Dulbecco's Modified Eagles Medium (DMEM) gekweek en gesupplementeer met 10% fetale beesserum en 1% penisillien-streptomysien. Die selle is blootgestel aan 'n 0.25mM mono onversadigde vetsuur (oleïensuur ) vir 24, 48 en 72 uur onderskeidelik. Die gekweekte selle is gevolglik ondersoek vir die graad van ROS ontwikkeling, algehele O-GlcNAsilering en seldood (apoptosis en nekrose), deur van vloeisitometrie en immunofluoresensie mikroskopie gebruik te maak. Resultate: Ons het bevind dat oleïensuur 'n betekenisvolle verlaging in ROS ontwikkeling teen 48 uur soos bepaal deur die vloeisitometer, veroorsaak. Dit wys daarop dat oleïensuur deur die selle op 'n onafhanklike wyse gemetaboliseer is. Oleïensuur het ook 'n betekenisvolle verlaging in seldood by alle tydsintervalle veroorsaak. Met betrekking tot die HBW het oleïensuur hierdie weg geaktiveer maar afstroom kardiobeskermings effekte versoorsaak wat nie noodwendig langs hierdie weg onstaan nie. Gevolgtrekking:Hierdie studie het die moontlikheid van 'n mono-onversadige vetsuur, oleïensuur, om op te tree as 'n nuwe kardiobeskermingsmiddel ondersoek. Die in vitro data ondersteun hierdie konsep en hier is aangetoon dat dit wel oksidatiewe stres en seldood onderdruk. Daar is verder bevind dat alhoewel oleïensuur die HBW aktiveer dit nie die beskermings effekte alleenlik via hierdie weg medieer nie.

A caseína e os ácidos graxos livres (AGL) são importantes componentes do leite relacionados às suas características industriais e sensoriais. Alguns fatores são responsáveis por alterações em suas concentrações, dentre eles, pode-se destacar as condições de armazenamento, além da agitação e, principalmente, a contagem de células somáticas (CCS). Para estudar tais alterações, avaliou-se através do presente estudo o efeito da temperatura de armazenamento (- 20oC e 7oC) e da idade das amostras (3, 6, 9 e 12 dias), assim como da CCS (CCS1: 400 mil, CCS2:400-750 mil e CCS3: 750 mil células somáticas/mL de leite). O efeito das condições de armazenamento sobre a caseína e os AGL foi avaliado no primeiro estudo. O efeito da CCS sobre a caseína e os AGL, por outro lado, foi avaliado no segundo estudo. No primeiro estudo, observou-se aumento nos teores de AGL ao longo do tempo, ou seja, acompanhando o aumento do período de armazenamento, com médias superiores em amostras resfriadas (7oC), em relação às congeladas (-20oC). Desta forma, sugere-se que análises laboratoriais devem ser realizadas em até três dias para este componente, devido ao seu aumento progressivo em amostras resfriadas. Para a caseína, entretanto, não foi identificada interação entre os fatores idade e temperatura. As médias deste componente não diferiram considerando-se as condições de armazenamento avaliadas, indicando que as análises para este componente podem ser realizadas até doze dias após a coleta, independente da temperatura de armazenamento. No segundo estudo, identificou-se interação entre classes de CCS e época de coleta, para caseína. A partir dos resultados de AGL, pode-se concluir que o leite encontra-se com altas concentrações deste componente, quando coletado na propriedade rural, sendo também observada influência da CCS sobre as concentrações de caseína e AGL no leite cru. Os AGL apresentaram incrementos significativos comparando-se amostras coletadas em diferentes locais, no trajeto da fazenda à indústria. Por outro lado, comparando-se os mesmos locais: tanque, rota e silo, as médias de caseína não diferiram. Observou-se correlação entre as variáveis CCS e caseína e CCS e AGL. / The casein and the free fatty acids (FFA) are important milk components related to its industrial and sensory characteristics. Some factors are responsible for changes in their concentration among them can highlight the storage conditions, as well as agitation and, especially, the somatic cell count (SCC). To study such changes, we assessed through the present study the effect of storage temperature (-20oC and 7oC) and the age of samples (3, 6, 9 e 12 days), as well as the CCS (CCS1: 400 mil; CCS2: 400-750 mil; CCS3: 750 mil somatic cells/mL of milk). The effect of CCS storage conditions on casein and FFA was evaluated in the first study. The effect of CCS on casein and FFA moreover, was evaluated in the second study. In the first study, it was observed increased levels the AGL over time, ie, accompanying the increase of the storage period, with means higher in refrigerated samples (7oC), in relation to frozen samples (- 20oC). Thus, it is suggested that laboratory examinations shall be performed up to three days to this component, due to their progressive increase in refrigerated samples. For casein, however, was not identified interaction between the factors age and temperature. The mean of this component did not differ considering the storage conditions, indicating that the analyzes for this component can be made until twelve days after collection, regardless of storage temperature. In the second study, we identified interactions between CCS classes and seasons, for casein. From the FFA results, we can conclude that milk meets with high concentrations of this component, when collected in the rural property, being also observed influence of CCS on concentrations of casein and FFA in raw milk. The FFA showed significant increases compared to samples collected at different locations on the path from farm to industry. On the other hand, comparing the same locations, tank, route and silo, the casein average did not differ. Correlation was observed between the variables casein and CCS and FFA and CCS.

Alterações metabólicas são muito frequentes em doentes graves. Sepse grave e choque séptico são condições clínicas muito prevalentes em unidades de terapia intensiva (UTI). A mortalidade da sepse grave e, especialmente do choque séptico, persiste alta, apesar das terapêuticas desenvolvidas nas últimas décadas. Controle rigoroso da glicemia parece ser uma terapia adjuvante muito importante, especialmente em doentes cirúrgicos graves. Ainda há controvérsias sobre o controle glicêmico rigoroso em doentes clínicos. Além da hiperglicemia, alguns estudos procuraram associar distúrbios no metabolismo de lipoproteínas e pior prognóstico para doentes graves. Também foi descrita a associação de hiperglicemia e quantidades mais baixas de lipoproteínas, sugerindo, possivelmente, o controle glicêmico rigoroso como fator importante para correção dos distúrbios do metabolismo de lipoproteínas. Neste estudo, dosamos LDL, HDL, triglicerídeos, colesterol total, ácidos graxos livres e Ox-LDL em 63 pacientes com diagnóstico de sepse grave ou choque séptico, divididos em dois grupos, sendo um grupo mantendo controle glicêmico rigoroso e outro grupo mantendo um controle glicêmico mais liberal, com internação em unidade de terapia intensiva (UTI) nas primeiras 72 horas de internação. Independentemente do grupo alocado, as concentrações séricas de LDL, HDL, colesterol total estiveram abaixo dos valores considerados normais. De outro modo, as concentrações séricas de ácidos graxos livres, triglicérides e Ox-LDL estiveram acima dos valores considerados normais. Ao longo das 72 horas houve manutenção das concentrações séricas de HDL e de colesterol total e das concentrações séricas elevados de ox-LDL e triglicérides. Houve um aumento progressivo das concentrações séricas de LDL e diminuição das concentrações séricas de ácidos graxos livres mais pronunciada nos doentes submetidos a controle glicêmico rigoroso. Ao longo do período de estudo, os pacientes sobreviventes apresentaram menores necessidades de insulina exógena, porém com concentrações séricas glicêmicas similares. As dosagens de Ox-LDL, LDL, HDL e PCR permaneceram similares entre os sobreviventes e os não sobreviventes / Metabolic disturbances are very frequent among critical care patients. Severe sepsis and septic shock are clinical conditions responsible for a great number of patients admitted to ICU. Severe sepsis and septic shock mortality rates remain high instead of new approaches developed in last decades. Intensive glycemic control appeared to be an important adjuvant therapy, especially among surgical intensive care patients. There are still some controversies about the benefits of intensive glycemic control among clinical intensive care patients. Beyond hyperglycemia, some studies have tried to associate lipid metabolism disturbances to worse prognosis. There are also descriptions of association between hyperglycemia and lower lipoproteins levels, suggesting the possible positive effects of intensive glycemic control and better control of lipid disturbances. In this study, we collected sequential serum LDL, HDL, triglycerides, total cholesterol, free fatty acids and Ox-LDL for 63 patients diagnosed as severe sepsis or septic shock admitted to ICU, in the first 72 hours after beginning of the symptoms. Patients were randomly allocated into two different groups, one for intensive glycemic control and the other maintaining more liberal glycemic levels. Results: Serum levels of LDL, HDL, and total cholesterol were below levels considered normal in both groups. Contrary, serum levels of free fatty acids, triglycerides and Ox-LDL were above normal levels in both groups. Along initial 72 hours we noticed a clear increase in LDL serum levels and decrease in free fatty acids serum levels more pronounced in the intensive glycemic control group. Survivors needed less dosages of exogenous insulin, despite of similar glycemic levels. Serum levels of Ox-LDL, LDL, HDL and CRP were similiar for survivors and non-survivors